Free Trial
→ My public warning after 55 years of watching the markets (From Weiss Ratings) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$2.61
$3.07
$1.84
▼
$28.00
$2.91M0.9253,151 shs37,029 shs
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$1.35
-12.7%		$1.80
$1.34
▼
$4.46
$11.64MN/A25,578 shs76,771 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover
The 7 Best High-Yield Dividend Stocks for 2027

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00%+11.06%-17.13%-37.86%-89.93%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-12.66%-13.78%-26.10%-17.99%-60.79%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
$2.61
$3.07
$1.84
▼
$28.00
$2.91M0.9253,151 shs37,029 shs
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$1.35
-12.7%		$1.80
$1.34
▼
$4.46
$11.64MN/A25,578 shs76,771 shs
The 7 Best High-Yield Dividend Stocks for 2027 Cover
The 7 Best High-Yield Dividend Stocks for 2027

Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
0.00%+11.06%-17.13%-37.86%-89.93%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-12.66%-13.78%-26.10%-17.99%-60.79%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
1.00
SellN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
2.50
Moderate Buy$9.50606.32% Upside

Current Analyst Ratings Breakdown

Latest SINT and BJDX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
10/15/2026
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
10/1/2026
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
Ascendiant Capital Markets logo
Ascendiant Capital Markets
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetBuy$12.00 ➝ $12.50
9/21/2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (E+)
(Data available from 11/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/A$33.73 per shareN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
$1.02M9.97N/AN/A$0.45 per share2.99
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$6.85M-$28.44N/AN/AN/AN/A-117.79%-95.05%N/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$10.36M-$1.69N/AN/AN/A-281.91%-309.86%-101.90%N/A

Latest SINT and BJDX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/12/2026Q3 2026
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
-$3,520.00-$1.72+$3,518.28-$1.72N/AN/A
11/5/2026Q3 2026
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
-$0.3067-$0.24+$0.0667-$0.24$1.33 million$2.19 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/AN/AN/AN/AN/A
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
N/A
4.64
4.64
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
N/A
1.84
1.60

Institutional Ownership

CompanyInstitutional Ownership
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
18.47%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
18.38%

Insider Ownership

CompanyInsider Ownership
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
6.10%
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
8.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Bluejay Diagnostics, Inc. stock logo
BJDX
Bluejay Diagnostics
61.12 million1.05 millionNot Optionable
Sintx Technologies, Inc. stock logo
SINT
Sintx Technologies
327.56 million6.95 millionNot Optionable

Recent News About These Companies

SINTX targets 2027 launch of 3D-printed implants
November 12 at 11:02 AM  |  beckersspine.comB
SINTX Technologies Advances SiN/PEEK 3D Printing Platform Toward Personalized Orthopedic Implant Commercialization
November 11 at 9:00 AM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/11/3400729/30038/en/sintx-technologies-advances-sin-peek-3d-printing-platform-toward-personalized-orthopedic-implant-commercialization.html
Sintx Technologies, Inc. (SINT) Q3 2026 Earnings Call Prepared Remarks Transcript
November 6, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4963547-sintx-technologies-inc-sint-q3-2026-earnings-call-prepared-remarks-transcript
Sintx Technologies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
November 6, 2026  |  marketscreener.comM
Transcript : Sintx Technologies, Inc., Q3 2026 Earnings Call, Nov 05, 2026
November 5, 2026  |  marketscreener.comM
SINTX Technologies Q3 2026 earnings call transcript
November 5, 2026  |  msn.comhttps://www.msn.com/en-us/technology/tech-companies/sintx-technologies-q3-2026-earnings-call-transcript/ar-AA2gQMu4
SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device Commercialization
November 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/05/3397017/30038/en/sintx-reports-record-third-quarter-2026-revenue-growth-and-advances-medical-device-commercialization.html
SINTX Technologies Announces Third Quarter 2026 Earnings Release Date and Webcast
October 22, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/22/3386426/30038/en/sintx-technologies-announces-third-quarter-2026-earnings-release-date-and-webcast.html
What Makes SINTX TECHNOLOGIES (SINT) a New Buy Stock
October 8, 2026  |  zacks.comhttps://www.zacks.com/stock/news/3003040/what-makes-sintx-technologies-sint-a-new-buy-stock?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_12_zacks_rank_upgrade-3003040
SINTX Technologies, Inc.: SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
October 2, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-10/69731595-sintx-technologies-inc-sintx-announces-preliminary-dollar-2-2-million-in-q3-revenue-exceeding-high-end-guidance-399.htm
Sintx Technologies, Inc. Reiterates Revenue Guidance for the Fourth Quarter of 2026
October 2, 2026  |  marketscreener.comM
SINTX reports preliminary $2.2M Q3 revenue, exceeds guidance and triggers call right on Class B warrants
October 2, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/sintx-reports-preliminary-22m-q3-revenue-exceeds-guidance-and-triggers-call-right-on-class-b-warrants/ar-AA2dmfJK
SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance
October 1, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/01/3372966/30038/en/sintx-announces-preliminary-2-2-million-in-q3-revenue-exceeding-high-end-guidance.html
SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts
September 14, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/14/3361164/30038/en/sintx-technologies-announces-silicon-nitride-masterclass-with-leading-orthopedics-experts.html
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/09/08/3357575/30038/en/sintx-technologies-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html
SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the Upgrade
August 19, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2977109/sintx-technologies-sint-moves-to-buy-rationale-behind-the-upgrade?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_12_zacks_rank_upgrade-2977109
SINTX Technologies, Inc.: SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement
August 13, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69304426-sintx-technologies-inc-sintx-technologies-regains-compliance-with-nasdaq-stockholders-equity-requirement-399.htm
SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344554/30038/en/sintx-technologies-regains-compliance-with-nasdaq-stockholders-equity-requirement.html
SINTX Technologies, Inc.: SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth ...
August 12, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69283117-sintx-technologies-inc-sintx-technologies-provides-mid-year-2026-business-update-highlighting-commercial-execution-biomaterial-platform-expansion-399.htm
SiNtx Technologies, Inc. (SINT) Q2 FY2026 earnings call transcript
August 12, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/quote/SINT/earnings/SINT-Q2-2026-earnings_call-691724.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Bluejay Diagnostics stock logo

Bluejay Diagnostics NASDAQ:BJDX

$2.61 0.00 (0.00%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$2.66 +0.04 (+1.72%)
As of 11/13/2026 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

Sintx Technologies stock logo

Sintx Technologies NASDAQ:SINT

$1.34 -0.20 (-12.66%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$1.40 +0.05 (+3.72%)
As of 11/13/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas